ATX
Click for more information
3.28% 6.3¢ amplia therapeutics limited

Ann: Amplia Reports First Patient Dosing In Phase 2a Accent Trial

  1. ASX News
    lightbulb Created with Sketch. 851
    clock Created with Sketch.
    17/01/24
    08:36
    Post #: 71914486
    Likes Created with Sketch. 16  Upvote
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

ITM iTech lifts MRE at Eyre Peninsula Graphite Project by 300%
right-arrow Created with Sketch.
BIO Biome posts record sales revenue of $13M in FY24 – up 80% vs pcp and higher than forecast
right-arrow Created with Sketch.
NEWS Week 26 Wrap: Cerberus of inflation barks – rents, electricity & fuel – and world watches two elders bicker
right-arrow Created with Sketch.
LLL Leo Lithium announces major divestment of flagship Goulamina project to Ganfeng
right-arrow Created with Sketch.
LRV Larvotto identifies new exploration target at NSW's Hillgrove, boosting shares by nearly 20%
right-arrow Created with Sketch.
EMD Emyria and UWA secure $499,411 grant to advance MDMA analogue drug program
right-arrow Created with Sketch.
watchlist Created with Sketch. Add ATX (ASX) to my watchlist
(20min delay)
Last
6.3¢ 		Change
0.002(3.28%) 		Mkt cap ! $17.11M
Open High Low Value Volume
6.2¢ 6.5¢ 6.1¢ $49.07K 778.9K

Buyers (Bids)

No. Vol. Price($)
1 1994 6.2¢
 

Sellers (Offers)

Price($) Vol. No.
6.3¢ 7737 1
View Market Depth
Last trade - 12.11pm 03/07/2024 (20 minute delay) ?
ATX (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.